EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Quality by Design Formulation Approach for the Development of Orodispersible Tablets of Dexlansoprazole

Arbab Tahir Ali iD, Fazli Nasir, Talaya Hidayatullah, Sadia Pervez, Syeda Rabqa Zainab, Shazma Gohar, Altaf Ur Rahman, Muzna Ali Khattak, Fawaz Alasmari, Steven H Neau, Gul E Maryam

Drug Design, Development and Therapy · 2025-05 · Volume 19 · 4163-4181

DOI: 10.2147/dddt.s515139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-05. Verfasst von Arbab Tahir Ali und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Peshawar, Peshawar, Pakistan. Hauptthemen laut MEDLINE: Dexlansoprazole, Proton Pump Inhibitors, Drug Design. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexlansoprazoleProton Pump InhibitorsDrug DesignTabletsHumansAdministration, OralDelayed-Action PreparationsChemistry, PharmaceuticalDrug CompoundingMaleAdult

Stichwörter der Autor:innen

FTIRODTdexlansoprazolepharmacokineticpolymerstability

Substanzen

TabletsDexlansoprazoleProton Pump InhibitorsDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Pharmacy, University of Peshawar, Peshawar, Pakistan.
  • Department of Pharmacy CECOS University Peshawar, Peshawar, Pakistan.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
  • Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, 19104, USA.
  • Department of Pharmacy, Qurtaba University of Science and Information Technology, Peshawar, 25000, Pakistan.

ORCID-Profile: Arbab Tahir Ali

Zitieren

APA

Ali, A. T., Nasir, F., Hidayatullah, T., Pervez, S., Rabqa Zainab, S., Gohar, S., Ur Rahman, A., Khattak, M. A., Alasmari, F., Neau, S. H., & Maryam, G. E. (2025). Quality by Design Formulation Approach for the Development of Orodispersible Tablets of Dexlansoprazole. Drug Design, Development and Therapy, Volume 19, 4163-4181. https://doi.org/10.2147/dddt.s515139

Vancouver

Ali AT, Nasir F, Hidayatullah T, Pervez S, Rabqa Zainab S, Gohar S, et al. Quality by Design Formulation Approach for the Development of Orodispersible Tablets of Dexlansoprazole. Drug Design, Development and Therapy. 2025;Volume 19:4163-4181. doi:10.2147/dddt.s515139

BibTeX
@article{Ali2025,
  author = {Ali, Arbab Tahir and Nasir, Fazli and Hidayatullah, Talaya and Pervez, Sadia and Rabqa Zainab, Syeda and Gohar, Shazma and Ur Rahman, Altaf and Khattak, Muzna Ali and Alasmari, Fawaz and Neau, Steven H and Maryam, Gul E},
  title = {Quality by Design Formulation Approach for the Development of Orodispersible Tablets of Dexlansoprazole},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {4163--4181},
  doi = {10.2147/dddt.s515139}
}
Kostenlos starten →